[Federal Register Volume 60, Number 225 (Wednesday, November 22, 1995)]
[Notices]
[Pages 57875-57876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-28442]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Meeting of the Advisory Committee to the Director, NIH
Pursuant to Public Law 92-463, notice is hereby given of the
meeting of the Advisory Committee to the Director, NIH, December 7,
1995, Conference Room 10, Building 31, National Institutes of Health,
Bethesda, Maryland 20892.
The entire meeting will be open to the public from 8:30 a.m. to
adjournment. The topics proposed for discussion include (1) Report from
the Recombinant DNA Ad Hoc Committee; (2) Report and Recommendations
from the Panel to Assesses the NIH Investment in Research on Gene
Therapy; (3) Report from the Economics Roundtable; (4) Status Report
from the Clinical Research Panel; and (5) Preliminary Report on the
Study of Options Regarding the Clinical Center. Attendance by the
public will be limited to space available.
Ms. Janice Ramsden, Program Assistant, Office of the Deputy
Director, National Institutes of Health, 1 Center
[[Page 57876]]
Drive MSC 0159, Bethesda, Maryland 20892-0159, telephone (301) 496-
0959, fax (301) 496-7451, will furnish the meeting agenda, roster of
committee members, and substantive program information upon request.
Any individual who requires special assistance, such as sign language
interpretation or other reasonable accommodations, should contact Ms.
Ramsden no later than November 28, 1995.
Dated: November 13, 1995.
Margery G. Grubb,
Senior Committee Management Specialist, National Institutes of the
Health.
[FR Doc. 95-28442 Filed 11-21-95; 8:45 am]
BILLING CODE 4140-01-M
